- Gilead Sciences Shares Gain After Positive Mortality and Recovery Data In Coronavirus Treatment StudyTheStreet
- Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patientsCNBC
- Gilead: Additional remdesivir data shows improved recoveryCNBC Television
- Coronavirus Treatment Remdesivir Cuts Down On Death; GILD Stock PopsInvestor’s Business Daily
- Gilead: Additional data on remdesivir shows improved clinical recoveryAOL
- View Full Coverage on Google News